Concepedia

Publication | Open Access

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis

DOIFull Paper Access

44

Citations

47

References

2015

Year

Christine Winchester, David Halpin, Ronald E. Dahl, Christoph Hallmann, Achim Mueller, Donald P. Tashkin
International Journal of COPD

Abstract

This analysis indicates that tiotropium is associated with lower rates of AEs, SAEs, and similar rates of FAEs than placebo when delivered via HandiHaler(®) or Respimat(®) (overall and separately) in patients with COPD.

References

YearCitations

Page 1